These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
221 related articles for article (PubMed ID: 33284237)
21. Liposomal irinotecan with fluorouracil and leucovorin after gemcitabine-based therapy in Japanese patients with metastatic pancreatic cancer: additional safety analysis of a randomized phase 2 trial. Furuse J; Ueno M; Ikeda M; Okusaka T; Teng Z; Furuya M; Ioka T Jpn J Clin Oncol; 2023 Jan; 53(2):130-137. PubMed ID: 36412114 [TBL] [Abstract][Full Text] [Related]
23. A phase I dose-escalation study (ISIDE-BT-1) of accelerated IMRT with temozolomide in patients with glioblastoma. Morganti AG; Balducci M; Salvati M; Esposito V; Romanelli P; Ferro M; Calista F; Digesù C; Macchia G; Ianiri M; Deodato F; Cilla S; Piermattei A; Valentini V; Cellini N; Cantore GP Int J Radiat Oncol Biol Phys; 2010 May; 77(1):92-7. PubMed ID: 19683876 [TBL] [Abstract][Full Text] [Related]
24. A phase I/II trial of irinotecan plus amrubicin supported with G-CSF for extended small-cell lung cancer. Harada T; Hamada A; Shimokawa M; Takayama K; Kudoh S; Maeno K; Saeki S; Miyawaki H; Moriyama A; Nakagawa K; Nakanishi Y Jpn J Clin Oncol; 2014 Feb; 44(2):127-33. PubMed ID: 24379211 [TBL] [Abstract][Full Text] [Related]
25. Safety, pharmacokinetics, and antitumor response of depatuxizumab mafodotin as monotherapy or in combination with temozolomide in patients with glioblastoma. Gan HK; Reardon DA; Lassman AB; Merrell R; van den Bent M; Butowski N; Lwin Z; Wheeler H; Fichtel L; Scott AM; Gomez EJ; Fischer J; Mandich H; Xiong H; Lee HJ; Munasinghe WP; Roberts-Rapp LA; Ansell PJ; Holen KD; Kumthekar P Neuro Oncol; 2018 May; 20(6):838-847. PubMed ID: 29077941 [TBL] [Abstract][Full Text] [Related]
26. A phase 1 trial of ABT-510 concurrent with standard chemoradiation for patients with newly diagnosed glioblastoma. Nabors LB; Fiveash JB; Markert JM; Kekan MS; Gillespie GY; Huang Z; Johnson MJ; Meleth S; Kuo H; Gladson CL; Fathallah-Shaykh HM Arch Neurol; 2010 Mar; 67(3):313-9. PubMed ID: 20212229 [TBL] [Abstract][Full Text] [Related]
27. NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors. Wang-Gillam A; Hubner RA; Siveke JT; Von Hoff DD; Belanger B; de Jong FA; Mirakhur B; Chen LT Eur J Cancer; 2019 Feb; 108():78-87. PubMed ID: 30654298 [TBL] [Abstract][Full Text] [Related]
28. A multi-site phase I trial of Veliparib with standard radiation and temozolomide in patients with newly diagnosed glioblastoma multiforme (GBM). Kleinberg L; Ye X; Supko J; Stevens GHJ; Shu HK; Mikkelsen T; Lieberman F; Lesser GJ; Lee E; Grossman SA J Neurooncol; 2023 Dec; 165(3):499-507. PubMed ID: 38015376 [TBL] [Abstract][Full Text] [Related]
29. Safety and efficacy of depatuxizumab mafodotin + temozolomide in patients with EGFR-amplified, recurrent glioblastoma: results from an international phase I multicenter trial. Lassman AB; van den Bent MJ; Gan HK; Reardon DA; Kumthekar P; Butowski N; Lwin Z; Mikkelsen T; Nabors LB; Papadopoulos KP; Penas-Prado M; Simes J; Wheeler H; Walbert T; Scott AM; Gomez E; Lee HJ; Roberts-Rapp L; Xiong H; Ansell PJ; Bain E; Holen KD; Maag D; Merrell R Neuro Oncol; 2019 Jan; 21(1):106-114. PubMed ID: 29982805 [TBL] [Abstract][Full Text] [Related]
30. Phase I trial of irinotecan plus temozolomide in adults with recurrent malignant glioma. Reardon DA; Quinn JA; Rich JN; Desjardins A; Vredenburgh J; Gururangan S; Sathornsumetee S; Badruddoja M; McLendon R; Provenzale J; Herndon JE; Dowell JM; Burkart JL; Newton HB; Friedman AH; Friedman HS Cancer; 2005 Oct; 104(7):1478-86. PubMed ID: 16088964 [TBL] [Abstract][Full Text] [Related]
31. Oxaliplatin plus irinotecan and leucovorin-modulated 5-fluorouracil triplet regimen every other week: a dose-finding study in patients with advanced gastrointestinal malignancies. Comella P; Casaretti R; De Rosa V; Avallone A; Izzo F; Fiore F; Lapenta L; Comella G Ann Oncol; 2002 Dec; 13(12):1874-81. PubMed ID: 12453855 [TBL] [Abstract][Full Text] [Related]
32. Phase 2 Study of Radiation Therapy Plus Low-Dose Temozolomide Followed by Temozolomide and Irinotecan for Glioblastoma: NRG Oncology RTOG Trial 0420. Lieberman FS; Wang M; Robins HI; Tsien CI; Curran WJ; Werner-Wasik M; Smith RP; Schultz C; Hartford AC; Zhang P; Mehta MP Int J Radiat Oncol Biol Phys; 2019 Mar; 103(4):878-886. PubMed ID: 30496882 [TBL] [Abstract][Full Text] [Related]
33. Phase I trial of hypofractionated intensity-modulated radiotherapy with temozolomide chemotherapy for patients with newly diagnosed glioblastoma multiforme. Chen C; Damek D; Gaspar LE; Waziri A; Lillehei K; Kleinschmidt-DeMasters BK; Robischon M; Stuhr K; Rusthoven KE; Kavanagh BD Int J Radiat Oncol Biol Phys; 2011 Nov; 81(4):1066-74. PubMed ID: 20932651 [TBL] [Abstract][Full Text] [Related]
34. Bevacizumab-containing regimen in relapsed/progressed brain tumors: a single-institution experience. Schiavetti A; Varrasso G; Mollace MG; Dominici C; Ferrara E; Papoff P; Di Biasi C Childs Nerv Syst; 2019 Jun; 35(6):1007-1012. PubMed ID: 30903281 [TBL] [Abstract][Full Text] [Related]
35. Phase 1 lead-in to a phase 2 factorial study of temozolomide plus memantine, mefloquine, and metformin as postradiation adjuvant therapy for newly diagnosed glioblastoma. Maraka S; Groves MD; Mammoser AG; Melguizo-Gavilanes I; Conrad CA; Tremont-Lukats IW; Loghin ME; O'Brien BJ; Puduvalli VK; Sulman EP; Hess KR; Aldape KD; Gilbert MR; de Groot JF; Alfred Yung WK; Penas-Prado M Cancer; 2019 Feb; 125(3):424-433. PubMed ID: 30359477 [TBL] [Abstract][Full Text] [Related]
36. Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer. Lee JL; Kang HJ; Kang YK; Ryu MH; Chang HM; Kim TW; Sohn HJ; Kim H; Lee JS Cancer Chemother Pharmacol; 2008 Apr; 61(5):837-45. PubMed ID: 17579864 [TBL] [Abstract][Full Text] [Related]
37. Salvage chemotherapy with mitomycin, docetaxel, and irinotecan (MDI regimen) in metastatic pancreatic adenocarcinoma: a phase I and II trial. Reni M; Panucci MG; Passoni P; Bonetto E; Nicoletti R; Ronzoni M; Zerbi A; Staudacher C; Di Carlo V; Villa E Cancer Invest; 2004; 22(5):688-96. PubMed ID: 15581049 [TBL] [Abstract][Full Text] [Related]
39. Temozolomide in radio-chemotherapy combined treatment for newly-diagnosed glioblastoma multiforme: phase II clinical trial. Lanzetta G; Campanella C; Rozzi A; Nappa M; Costa A; Fedele F; Innocenzi G; Gagliardi FM; Salvati M; Minniti G; Frati A; Frati L; Vecchione A Anticancer Res; 2003; 23(6D):5159-64. PubMed ID: 14981983 [TBL] [Abstract][Full Text] [Related]
40. A Phase I Study of a Combination of Liposomal Irinotecan and Veliparib in Solid Tumors. LaRose M; Connolly RM; O'Sullivan CC; Velcheti V; Vilimas R; Gano K; Bates SE; Pommier Y; Thomas A Oncologist; 2023 May; 28(5):460-e298. PubMed ID: 37010988 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]